NCT06109428View on ClinicalTrials.gov

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

March 29, 2022

Study Completion Date

April 7, 2022

Conditions
Analgesia
Interventions
DRUG

HTX-011

400 mg

DRUG

Bupivacaine Hydrochloride

125 mg

DRUG

Ibuprofen

400 mg

DRUG

Acetaminophen

1 g

DEVICE

Luer lock applicator

Applicator for instillation

Trial Locations (2)

77401

First Surgical Hospital, Bellaire

78229

Endeavor Clinical Trials, LLC, San Antonio

Sponsors

Lead Sponsor

Heron Therapeutics
All Listed Sponsors
lead

Heron Therapeutics

INDUSTRY